Taken together, these results suggested that xCT is essential for the growth and development of NSCLC cells in vitro and in vivo, and knockdown of xCT reduces the cell invasion and glutamine dependency in NSCLC. The gene discussed is SLC7A11; the disease is non-small cell lung carcinoma.